|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Ƥ��,֬���� |
|
ͷƤƤ���� |
| ��������������� | |
|
����� |
|
���� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
ͷƤм���о���չ
�����, ����, ������
������ѧ������ɽҽԺƤ���� �Ϻ� 200040
ͷƤм�Ķ����Լ���������������δ��ȷ������֯����ѧ��,ͷƤм���Ǽ�����֢���� ;�ٴ��۲쵽��ȴ�Ƿ���֢״̬����Ƥ����ѧ�о�����,ͷƤ�Ľ��ʲ�ϸ�������ź�ͬ�����,��ֱ������0.2mmʱ�����ۿɼ�,��Ϊ��ͷƤм��������ɫ����ͷƤм�ķ��������س̶��������,�ҿ����������йء�����,�����������ؿ��ܺ�ͷƤм�ķ�����ء�
[2] Pierard-Franchimont C, Hermanns JF, Degreef H, et al. From axioms to new insights into dandruff. Dermatology, 2000, 200:93-98.
[3] Conti Diaz IA, Civila E, Veiga R. The importance of microscopic examination in the management of desquamative diseases of the scalp.Mycopathologia, 2002, 153:71-75.
[4] Warner RR, Schwartz JR, Boissy Y, et al. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dernatol, 2001, 45:897-903.
[5] Watanabe S, Kano R, Sato H, et al. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol,2001, 116:769-773.
[6] Schmidt A. Malassezia furfur: a fungus belonging to the physiological skin flora and its relevance in skin disorders. Cutis, 1997, 59:21-24.
[7] Gueho E, Faergemann J, Lyman C, et al. Malassezia and Trichosporou: two emerging pathogenic basidiomycetous yeast-like fungi. J Med Vet Mycol, 1994, 32:367-378.
[8] Pierard-Franchimont C, Goffin V, Decroix J, et al. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol, 2002, 15:434-441.
[9] Satchell AC, Saurajen A, Bell C, et al. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol, 2002, 4-7:852-855.
[10] Al-Waili NS. Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff. Eur J Med Res, 2001, 6:306-308.
[11] Hood S, Denning DW. Treatment of fungal infection in AIDS. J Antimicrob Chemother, 1996, 37:71-85.
[12] Ippolito F, Passi S, Di Carlo A. Is seborrhoeic dermatitis a clinical marker of HIV disease? Minerva Ginecol, 2000, 52:54-58.
[13] Ashbee HR, Fruin A, Holland KT, et al. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp Dermatol, 1994, 3:227-233.
[14] Harding CR, Moore AE, Rogers JS, et al. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol Res,2002, 294:221-230.
[15] Allen M, Ishida-Yamamoto A, McGrath J, et al. Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders. Lab Invest, 2001, 81:969-976.
[16] Perkins MA, Cardin CW, Osterhues MA, et al. A non-invasive tape absorption method for recovery of inflammatory mediators to differentiate normal from compromised scalp conditions. Skin Res Technol,2002, 8:187-193.
[17] Radeff S, Micheff V, Popova S. ABO-genetic system, susceptibility towards multiple skin affections and sexual activity. J Eur Acad Dermatol Venereol Supp1,2002,16:210.